Matches in SemOpenAlex for { <https://semopenalex.org/work/W2665748045> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2665748045 endingPage "e83" @default.
- W2665748045 startingPage "e83" @default.
- W2665748045 abstract "Therapeutic drug monitoring (TDM) of both aminoglycoside antibiotics (amikacin, gentamicin) and vancomycin is special method of clinical pharmacology using measurement of drug serum levels followed by interpretation and good cooperation with clinician. TDM helps in the dose adjustment of antibiotics according to the characteristics of a individual patient, in the lowering of toxicity and in the increasing of treatment cost-effectiveness. Vancomycin, gentamicin and amikacin levels were measured and antibiotics doses were adjusted on the basis of interdisciplinary cooperation between clinical pharmacologists and clinicians during seven years (2009-2015). Serum levels were analysed by immunoassay and LC-MS/MS method, dosage of antibiotics was changed using software MWPharm version 3.30. As an indicator of the quality assessment were used trough levels of gentamicin < 2.0 mg/L (or < 1.0 mg/L for once-daily since year 2013), amikacin < 10.0 mg/L (or < 5.0 mg/L for once-daily since year 2013) and vancomycin < 15.0 mg/L (< 20.0 mg/L since year 2013). The incidence of potentially toxic levels of the drugs was monitored monthly as an indicator of the quality of medical care and analysis of the causes of potentially toxic levels was done. Potentially toxic antibiotics levels were measured in 9 patients (1.1%) in year 2009 versus 5 patients (0.5 %) in year 2015 because the dose adjustment recommendations were not accepted by clinicians. The rate of potentially toxic levels after vancomycin initial dose in year 2015 was lower in comparison with report of the University of California San Francisco (3% versus 17%). Close contact between clinicians and clinical pharmacologists has led to a significantly lower incidence of the potentially toxic levels. Routine therapeutic drug monitoring of vancomycin and aminoglycoside antibiotics can reduce the risk of toxicity and improve the safety of health care." @default.
- W2665748045 created "2017-06-30" @default.
- W2665748045 creator A5038770128 @default.
- W2665748045 creator A5052372415 @default.
- W2665748045 date "2017-08-01" @default.
- W2665748045 modified "2023-09-26" @default.
- W2665748045 title "Tdm of Aminoglycoside Antibiotics and Vancomycin as an Indicator of the Quality of Medical Care: Results of the 7-Years Monitoring" @default.
- W2665748045 doi "https://doi.org/10.1016/j.clinthera.2017.05.256" @default.
- W2665748045 hasPublicationYear "2017" @default.
- W2665748045 type Work @default.
- W2665748045 sameAs 2665748045 @default.
- W2665748045 citedByCount "0" @default.
- W2665748045 crossrefType "journal-article" @default.
- W2665748045 hasAuthorship W2665748045A5038770128 @default.
- W2665748045 hasAuthorship W2665748045A5052372415 @default.
- W2665748045 hasBestOaLocation W26657480451 @default.
- W2665748045 hasConcept C126322002 @default.
- W2665748045 hasConcept C177713679 @default.
- W2665748045 hasConcept C2775832221 @default.
- W2665748045 hasConcept C2777288759 @default.
- W2665748045 hasConcept C2777427914 @default.
- W2665748045 hasConcept C2777787772 @default.
- W2665748045 hasConcept C2778980435 @default.
- W2665748045 hasConcept C2779489039 @default.
- W2665748045 hasConcept C2780035454 @default.
- W2665748045 hasConcept C2780272996 @default.
- W2665748045 hasConcept C2910800852 @default.
- W2665748045 hasConcept C501593827 @default.
- W2665748045 hasConcept C523546767 @default.
- W2665748045 hasConcept C54355233 @default.
- W2665748045 hasConcept C71924100 @default.
- W2665748045 hasConcept C86803240 @default.
- W2665748045 hasConcept C89423630 @default.
- W2665748045 hasConcept C98274493 @default.
- W2665748045 hasConceptScore W2665748045C126322002 @default.
- W2665748045 hasConceptScore W2665748045C177713679 @default.
- W2665748045 hasConceptScore W2665748045C2775832221 @default.
- W2665748045 hasConceptScore W2665748045C2777288759 @default.
- W2665748045 hasConceptScore W2665748045C2777427914 @default.
- W2665748045 hasConceptScore W2665748045C2777787772 @default.
- W2665748045 hasConceptScore W2665748045C2778980435 @default.
- W2665748045 hasConceptScore W2665748045C2779489039 @default.
- W2665748045 hasConceptScore W2665748045C2780035454 @default.
- W2665748045 hasConceptScore W2665748045C2780272996 @default.
- W2665748045 hasConceptScore W2665748045C2910800852 @default.
- W2665748045 hasConceptScore W2665748045C501593827 @default.
- W2665748045 hasConceptScore W2665748045C523546767 @default.
- W2665748045 hasConceptScore W2665748045C54355233 @default.
- W2665748045 hasConceptScore W2665748045C71924100 @default.
- W2665748045 hasConceptScore W2665748045C86803240 @default.
- W2665748045 hasConceptScore W2665748045C89423630 @default.
- W2665748045 hasConceptScore W2665748045C98274493 @default.
- W2665748045 hasIssue "8" @default.
- W2665748045 hasLocation W26657480451 @default.
- W2665748045 hasOpenAccess W2665748045 @default.
- W2665748045 hasPrimaryLocation W26657480451 @default.
- W2665748045 hasRelatedWork W1979615861 @default.
- W2665748045 hasRelatedWork W2002550359 @default.
- W2665748045 hasRelatedWork W2022806706 @default.
- W2665748045 hasRelatedWork W2069600381 @default.
- W2665748045 hasRelatedWork W2133394016 @default.
- W2665748045 hasRelatedWork W2477071490 @default.
- W2665748045 hasRelatedWork W2665748045 @default.
- W2665748045 hasRelatedWork W2945913530 @default.
- W2665748045 hasRelatedWork W3209878112 @default.
- W2665748045 hasRelatedWork W4360614711 @default.
- W2665748045 hasVolume "39" @default.
- W2665748045 isParatext "false" @default.
- W2665748045 isRetracted "false" @default.
- W2665748045 magId "2665748045" @default.
- W2665748045 workType "article" @default.